<< Back to News

System Formulary Update
Asparaginase Erwinia Chrysanthemi (Recombinant) – rywn (Rylaze)

Situation

Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn (Rylaze) 10 mg/0.5 mL SDV for injection was approved for addition to the health system formulary at the July 2023 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was reviewed: Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn (Rylaze) 10 mg/0.5 mL SDV for injection

Assessment/Recommendation

System P&T voted to include the following products on the UNC Health Medication Formulary with RESTRICTIONS:

• Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn (Rylaze) 10 mg/0.5 mL SDV for injection

Note: Stock of this formulary product may vary at individual entities

Formulary/Epic changes will Go-Live on Tuesday, August 29, 2023